L-3-hydroxyacyl-CoA dehydrogenase II protects in a model of Parkinson's disease

Kim Tieu, Celine Perier, Miquel Vila, Casper Caspersen, Hui Ping Zhang, Peter Teismann, Vernice Jackson-Lewis, David Stern, Shi Du Yan, Serge Przedborski

Research output: Contribution to journalArticle

34 Citations (Scopus)

Abstract

The neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) impairs mitochondrial respiration and damages dopaminergic neurons as seen in Parkinson's disease (PD). Here, we report that L-3-hydroxyacyl-CoA dehydrogenase type II/amyloid binding alcohol dehydrogenase (HADH II/ABAD), a mitochondrial oxidoreductase enzyme involved in neuronal survival, is downregulated in PD patients and in MPTP-intoxicated mice. We also show that transgenic mice with increased expression of human HADH II/ABAD are significantly more resistant to MPTP than their wild-type littermates. This effect appears to be mediated by overexpression of HADH II/ABAD mitigating MPTP-induced impairment of oxidative phosphorylation and ATP production. This study demonstrates that HADH II/ABAD modulates MPTP neurotoxicity and suggests that HADH II/ABAD mimetics may provide protective benefit in the treatment of PD.

Original languageEnglish (US)
Pages (from-to)51-60
Number of pages10
JournalAnnals of Neurology
Volume56
Issue number1
DOIs
StatePublished - Jan 1 2004

Fingerprint

3-Hydroxyacyl-CoA Dehydrogenase
Alcohol Dehydrogenase
Amyloid
Parkinson Disease
Coenzyme A
Oxidoreductases
1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine
Dopaminergic Neurons
Oxidative Phosphorylation
Neurotoxins
Transgenic Mice
Respiration
Down-Regulation
Adenosine Triphosphate
4-phenyl-1,2,3,6-tetrahydropyridine
Enzymes

All Science Journal Classification (ASJC) codes

  • Neurology
  • Clinical Neurology

Cite this

Tieu, K., Perier, C., Vila, M., Caspersen, C., Zhang, H. P., Teismann, P., ... Przedborski, S. (2004). L-3-hydroxyacyl-CoA dehydrogenase II protects in a model of Parkinson's disease. Annals of Neurology, 56(1), 51-60. https://doi.org/10.1002/ana.20133

L-3-hydroxyacyl-CoA dehydrogenase II protects in a model of Parkinson's disease. / Tieu, Kim; Perier, Celine; Vila, Miquel; Caspersen, Casper; Zhang, Hui Ping; Teismann, Peter; Jackson-Lewis, Vernice; Stern, David; Yan, Shi Du; Przedborski, Serge.

In: Annals of Neurology, Vol. 56, No. 1, 01.01.2004, p. 51-60.

Research output: Contribution to journalArticle

Tieu, K, Perier, C, Vila, M, Caspersen, C, Zhang, HP, Teismann, P, Jackson-Lewis, V, Stern, D, Yan, SD & Przedborski, S 2004, 'L-3-hydroxyacyl-CoA dehydrogenase II protects in a model of Parkinson's disease', Annals of Neurology, vol. 56, no. 1, pp. 51-60. https://doi.org/10.1002/ana.20133
Tieu K, Perier C, Vila M, Caspersen C, Zhang HP, Teismann P et al. L-3-hydroxyacyl-CoA dehydrogenase II protects in a model of Parkinson's disease. Annals of Neurology. 2004 Jan 1;56(1):51-60. https://doi.org/10.1002/ana.20133
Tieu, Kim ; Perier, Celine ; Vila, Miquel ; Caspersen, Casper ; Zhang, Hui Ping ; Teismann, Peter ; Jackson-Lewis, Vernice ; Stern, David ; Yan, Shi Du ; Przedborski, Serge. / L-3-hydroxyacyl-CoA dehydrogenase II protects in a model of Parkinson's disease. In: Annals of Neurology. 2004 ; Vol. 56, No. 1. pp. 51-60.
@article{267ec05d79cc43b48c5bf6b46182c202,
title = "L-3-hydroxyacyl-CoA dehydrogenase II protects in a model of Parkinson's disease",
abstract = "The neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) impairs mitochondrial respiration and damages dopaminergic neurons as seen in Parkinson's disease (PD). Here, we report that L-3-hydroxyacyl-CoA dehydrogenase type II/amyloid binding alcohol dehydrogenase (HADH II/ABAD), a mitochondrial oxidoreductase enzyme involved in neuronal survival, is downregulated in PD patients and in MPTP-intoxicated mice. We also show that transgenic mice with increased expression of human HADH II/ABAD are significantly more resistant to MPTP than their wild-type littermates. This effect appears to be mediated by overexpression of HADH II/ABAD mitigating MPTP-induced impairment of oxidative phosphorylation and ATP production. This study demonstrates that HADH II/ABAD modulates MPTP neurotoxicity and suggests that HADH II/ABAD mimetics may provide protective benefit in the treatment of PD.",
author = "Kim Tieu and Celine Perier and Miquel Vila and Casper Caspersen and Zhang, {Hui Ping} and Peter Teismann and Vernice Jackson-Lewis and David Stern and Yan, {Shi Du} and Serge Przedborski",
year = "2004",
month = "1",
day = "1",
doi = "10.1002/ana.20133",
language = "English (US)",
volume = "56",
pages = "51--60",
journal = "Annals of Neurology",
issn = "0364-5134",
publisher = "John Wiley and Sons Inc.",
number = "1",

}

TY - JOUR

T1 - L-3-hydroxyacyl-CoA dehydrogenase II protects in a model of Parkinson's disease

AU - Tieu, Kim

AU - Perier, Celine

AU - Vila, Miquel

AU - Caspersen, Casper

AU - Zhang, Hui Ping

AU - Teismann, Peter

AU - Jackson-Lewis, Vernice

AU - Stern, David

AU - Yan, Shi Du

AU - Przedborski, Serge

PY - 2004/1/1

Y1 - 2004/1/1

N2 - The neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) impairs mitochondrial respiration and damages dopaminergic neurons as seen in Parkinson's disease (PD). Here, we report that L-3-hydroxyacyl-CoA dehydrogenase type II/amyloid binding alcohol dehydrogenase (HADH II/ABAD), a mitochondrial oxidoreductase enzyme involved in neuronal survival, is downregulated in PD patients and in MPTP-intoxicated mice. We also show that transgenic mice with increased expression of human HADH II/ABAD are significantly more resistant to MPTP than their wild-type littermates. This effect appears to be mediated by overexpression of HADH II/ABAD mitigating MPTP-induced impairment of oxidative phosphorylation and ATP production. This study demonstrates that HADH II/ABAD modulates MPTP neurotoxicity and suggests that HADH II/ABAD mimetics may provide protective benefit in the treatment of PD.

AB - The neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) impairs mitochondrial respiration and damages dopaminergic neurons as seen in Parkinson's disease (PD). Here, we report that L-3-hydroxyacyl-CoA dehydrogenase type II/amyloid binding alcohol dehydrogenase (HADH II/ABAD), a mitochondrial oxidoreductase enzyme involved in neuronal survival, is downregulated in PD patients and in MPTP-intoxicated mice. We also show that transgenic mice with increased expression of human HADH II/ABAD are significantly more resistant to MPTP than their wild-type littermates. This effect appears to be mediated by overexpression of HADH II/ABAD mitigating MPTP-induced impairment of oxidative phosphorylation and ATP production. This study demonstrates that HADH II/ABAD modulates MPTP neurotoxicity and suggests that HADH II/ABAD mimetics may provide protective benefit in the treatment of PD.

UR - http://www.scopus.com/inward/record.url?scp=3042836950&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=3042836950&partnerID=8YFLogxK

U2 - 10.1002/ana.20133

DO - 10.1002/ana.20133

M3 - Article

VL - 56

SP - 51

EP - 60

JO - Annals of Neurology

JF - Annals of Neurology

SN - 0364-5134

IS - 1

ER -